Dennis Langer, Director at Dicerna Pharmaceuticals Inc (DRNA), sold 38,341 shares at $16.00 ($613K) on 2018-08-15, disclosed to the SEC on 2018-08-17.
Open-market sale of $613k DRNA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.00 | 14,531 | $232K | 37.9% |
| 2 | $16.00 | 23,810 | $381K | 62.1% |
| Total | $16.00 avg | 38,341 | $613K | 100% |
| Filing → |
| MYGN | SELL | 2021-08-05 | $1.0M | — | Filing → |
| MYGN | SELL | 2018-06-08 | $1.6M | — | Filing → |
| MYGN | SELL | 2018-06-05 | $2.0M | — | Filing → |